REPORTS

Let’s Pullulate and Expand Your Business

Binge Eating Disorder Drug Market - Global Professional Analysis and Forecast to 2026

Feb 08, 2020  |  209 PAGES  |  REPORT CODE: CMM265661
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Binge Eating Disorder Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.4% during the forecast period.

This report presents the market size and development trends by detailing the Binge Eating Disorder Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Binge Eating Disorder Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Binge Eating Disorder Drug industry and will help you to build a panoramic view of the industrial development.

Binge Eating Disorder Drug Market, By Type:

  • Antidepressants

  • Anticonvulsants

  • Anti-obesity Medications

Binge Eating Disorder Drug Market, By Application:

  • Retail Pharmacies

  • Hospital Pharmacies

  • Online Pharmacies

Some of the leading players are as follows:

  • Roche

  • Novo Nordisk

  • Opiant Pharmaceuticals

  • Omeros Corp

  • Chronos Therapeutics

  • Heptares

  • Sunovion Pharmaceuticals

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Binge Eating Disorder Drug Market: Technology Type Analysis

  • 4.1 Binge Eating Disorder Drug Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Binge Eating Disorder Drug Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Antidepressants

    • 4.3.2 Anticonvulsants

    • 4.3.3 Anti-obesity Medications

5 Binge Eating Disorder Drug Market: Product Analysis

  • 5.1 Binge Eating Disorder Drug Product Market Share Analysis, 2018 & 2026

  • 5.2 Binge Eating Disorder Drug Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Binge Eating Disorder Drug Market: Application Analysis

  • 6.1 Binge Eating Disorder Drug Application Market Share Analysis, 2018 & 2026

  • 6.2 Binge Eating Disorder Drug Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Retail Pharmacies

    • 6.3.2 Hospital Pharmacies

    • 6.3.3 Online Pharmacies

7 Binge Eating Disorder Drug Market: Regional Analysis

  • 7.1 Binge Eating Disorder Drug Regional Market Share Analysis, 2018 & 2026

  • 7.2 Binge Eating Disorder Drug Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Roche

    • 9.1.1 Roche Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Novo Nordisk

    • 9.2.1 Novo Nordisk Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Opiant Pharmaceuticals

    • 9.3.1 Opiant Pharmaceuticals Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Omeros Corp

    • 9.4.1 Omeros Corp Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Chronos Therapeutics

    • 9.5.1 Chronos Therapeutics Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Heptares

    • 9.6.1 Heptares Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Sunovion Pharmaceuticals

    • 9.7.1 Sunovion Pharmaceuticals Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

 

The List of Tables and Figures (Totals 111 Figures and 153 Tables)

  • Figure Antidepressants Binge Eating Disorder Drug market, 2015 - 2026 (USD Million)

  • Figure Anticonvulsants Binge Eating Disorder Drug market, 2015 - 2026 (USD Million)

  • Figure Anti-obesity Medications Binge Eating Disorder Drug market, 2015 - 2026 (USD Million)

  • Figure Retail Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Online Pharmacies market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Binge Eating Disorder Drug market, by country, 2015 - 2026 (USD Million)

  • Table North America Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table North America Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table North America Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Canada Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Canada Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Europe Binge Eating Disorder Drug market, by country, 2015 - 2026 (USD Million)

  • Table Europe Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Europe Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Europe Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Germany Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Germany Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table France Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table France Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Italy Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Italy Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Spain Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Spain Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Binge Eating Disorder Drug market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table China Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table China Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Japan Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Japan Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table India Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table India Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Binge Eating Disorder Drug market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table MEA Binge Eating Disorder Drug market, by country, 2015 - 2026 (USD Million)

  • Table MEA Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table MEA Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table MEA Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Binge Eating Disorder Drug market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Binge Eating Disorder Drug market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Binge Eating Disorder Drug market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Opiant Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Omeros Corp Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Chronos Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Heptares Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sunovion Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top